Martin (nuvonuro)-HIT to lead chemistry-admet only- mcsp-heal
Ended Awarded Last action
- Contract number
- 75N95023F00002
- Awardee
-
Curia Global Inc. UEI ELCNZCS8GEA3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $256,491
Award facts
- Opportunity
-
- TORFPNIHNINDS2302 Solicitation number
- Contract value 39% obligated
-
- $256,490.65 Current, with exercised options
- $662,706.10 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albany, NY 12212, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $256,491 |
About this award
This is a delivery order awarded to Curia Global Inc., doing business as Amri, by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke. The $662,706.10 cost-plus-fixed-fee contract is to provide chemistry and absorption/distribution/metabolism/excretion (ADMET) services in support of the Medicinal Chemistry Support Program (MCSP) and other NIH initiatives related to neurology, infectious diseases, and substance abuse research and development. This is not a set-aside contract. Curia is a leading contract development and manufacturing organization (CDMO) that has extensive experience supporting pharmaceutical R&D for federal agencies like NIH through various prime and subcontract awards, including programs focused on drug discovery, manufacturing, and testing.
Quick answers
Who was awarded contract 75N95023F00002?
75N95023F00002 was awarded to Curia Global Inc. by National Institute on Drug Abuse (National Institutes of Health) on August 1, 2023.
How much is contract 75N95023F00002 worth?
The government has obligated $256,491 on 75N95023F00002. Its potential value, with all options, is $662,706.
Which agency awarded contract 75N95023F00002?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95023F00002, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Is contract 75N95023F00002 an order under another contract?
Yes. 75N95023F00002 is a delivery order under HHSN271201800001I, an indefinite delivery contract.
Was contract 75N95023F00002 competed?
The extent of competition for 75N95023F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award